186 related articles for article (PubMed ID: 36947859)
1. A bispecific inhibitor of complement and coagulation blocks activation in complementopathy models via a novel mechanism.
Andersen JF; Lei H; Strayer EC; Kanai T; Pham V; Pan XZ; Alvarenga PH; Gerber GF; Asojo OA; Francischetti IMB; Brodsky RA; Valenzuela JG; Ribeiro JMC
Blood; 2023 Jun; 141(25):3109-3121. PubMed ID: 36947859
[TBL] [Abstract][Full Text] [Related]
2. 3D structure of the C3bB complex provides insights into the activation and regulation of the complement alternative pathway convertase.
Torreira E; Tortajada A; Montes T; Rodríguez de Córdoba S; Llorca O
Proc Natl Acad Sci U S A; 2009 Jan; 106(3):882-7. PubMed ID: 19136636
[TBL] [Abstract][Full Text] [Related]
3. Lufaxin, a novel factor Xa inhibitor from the salivary gland of the sand fly Lutzomyia longipalpis blocks protease-activated receptor 2 activation and inhibits inflammation and thrombosis in vivo.
Collin N; Assumpção TC; Mizurini DM; Gilmore DC; Dutra-Oliveira A; Kotsyfakis M; Sá-Nunes A; Teixeira C; Ribeiro JM; Monteiro RQ; Valenzuela JG; Francischetti IM
Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2185-98. PubMed ID: 22796577
[TBL] [Abstract][Full Text] [Related]
4. The Sand Fly Salivary Protein Lufaxin Inhibits the Early Steps of the Alternative Pathway of Complement by Direct Binding to the Proconvertase C3b-B.
Mendes-Sousa AF; do Vale VF; Silva NCS; Guimaraes-Costa AB; Pereira MH; Sant'Anna MRV; Oliveira F; Kamhawi S; Ribeiro JMC; Andersen JF; Valenzuela JG; Araujo RN
Front Immunol; 2017; 8():1065. PubMed ID: 28912782
[TBL] [Abstract][Full Text] [Related]
5. Coexistence of closed and open conformations of complement factor B in the alternative pathway C3bB(Mg2+) proconvertase.
Torreira E; Tortajada A; Montes T; Rodríguez de Córdoba S; Llorca O
J Immunol; 2009 Dec; 183(11):7347-51. PubMed ID: 19890040
[TBL] [Abstract][Full Text] [Related]
6. A novel antibody against human factor B that blocks formation of the C3bB proconvertase and inhibits complement activation in disease models.
Subías M; Tortajada A; Gastoldi S; Galbusera M; López-Perrote A; Lopez Lde J; González-Fernández FA; Villegas-Martínez A; Dominguez M; Llorca O; Noris M; Morgan BP; Rodríguez de Córdoba S
J Immunol; 2014 Dec; 193(11):5567-75. PubMed ID: 25355917
[TBL] [Abstract][Full Text] [Related]
7. Structures of C3b in complex with factors B and D give insight into complement convertase formation.
Forneris F; Ricklin D; Wu J; Tzekou A; Wallace RS; Lambris JD; Gros P
Science; 2010 Dec; 330(6012):1816-20. PubMed ID: 21205667
[TBL] [Abstract][Full Text] [Related]
8. Insights Into Enhanced Complement Activation by Structures of Properdin and Its Complex With the C-Terminal Domain of C3b.
van den Bos RM; Pearce NM; Granneman J; Brondijk THC; Gros P
Front Immunol; 2019; 10():2097. PubMed ID: 31552043
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of complement inhibition by a mosquito protein revealed through cryo-EM.
Andersen JF; Lei H; Strayer EC; Pham V; Ribeiro JMC
Commun Biol; 2024 May; 7(1):649. PubMed ID: 38802531
[TBL] [Abstract][Full Text] [Related]
10. Insights into the Effects of Complement Factor H on the Assembly and Decay of the Alternative Pathway C3 Proconvertase and C3 Convertase.
Bettoni S; Bresin E; Remuzzi G; Noris M; Donadelli R
J Biol Chem; 2016 Apr; 291(15):8214-30. PubMed ID: 26903516
[TBL] [Abstract][Full Text] [Related]
11. Quantification of the zymogenicity and the substrate-induced activity enhancement of complement factor D.
Dani R; Oroszlán G; Martinusz R; Farkas B; Dobos B; Vadas E; Závodszky P; Gál P; Dobó J
Front Immunol; 2023; 14():1197023. PubMed ID: 37283768
[TBL] [Abstract][Full Text] [Related]
12. Factor D Inhibition Blocks Complement Activation Induced by Mutant Factor B Associated With Atypical Hemolytic Uremic Syndrome and Membranoproliferative Glomerulonephritis.
Aradottir SS; Kristoffersson AC; Roumenina LT; Bjerre A; Kashioulis P; Palsson R; Karpman D
Front Immunol; 2021; 12():690821. PubMed ID: 34177949
[TBL] [Abstract][Full Text] [Related]
13. Insights into complement convertase formation based on the structure of the factor B-cobra venom factor complex.
Janssen BJ; Gomes L; Koning RI; Svergun DI; Koster AJ; Fritzinger DC; Vogel CW; Gros P
EMBO J; 2009 Aug; 28(16):2469-78. PubMed ID: 19574954
[TBL] [Abstract][Full Text] [Related]
14. The role of properdin in the assembly of the alternative pathway C3 convertases of complement.
Hourcade DE
J Biol Chem; 2006 Jan; 281(4):2128-32. PubMed ID: 16301317
[TBL] [Abstract][Full Text] [Related]
15. Factor H-related protein 4 activates complement by serving as a platform for the assembly of alternative pathway C3 convertase via its interaction with C3b protein.
Hebecker M; Józsi M
J Biol Chem; 2012 Jun; 287(23):19528-36. PubMed ID: 22518841
[TBL] [Abstract][Full Text] [Related]
16. Identification of the C3b binding site in a recombinant vWF-A domain of complement factor B by surface-enhanced laser desorption-ionisation affinity mass spectrometry and homology modelling: implications for the activity of factor B.
Hinshelwood J; Spencer DI; Edwards YJ; Perkins SJ
J Mol Biol; 1999 Nov; 294(2):587-99. PubMed ID: 10610782
[TBL] [Abstract][Full Text] [Related]
17. Decay-accelerating factor must bind both components of the complement alternative pathway C3 convertase to mediate efficient decay.
Harris CL; Pettigrew DM; Lea SM; Morgan BP
J Immunol; 2007 Jan; 178(1):352-9. PubMed ID: 17182573
[TBL] [Abstract][Full Text] [Related]
18. Increased enzymatic activity of the alternative pathway convertase when bound to the erythrocytes of paroxysmal nocturnal hemoglobinuria.
Parker CJ; Baker PJ; Rosse WF
J Clin Invest; 1982 Feb; 69(2):337-46. PubMed ID: 6915939
[TBL] [Abstract][Full Text] [Related]
19. Complement factor B mutations in atypical hemolytic uremic syndrome-disease-relevant or benign?
Marinozzi MC; Vergoz L; Rybkine T; Ngo S; Bettoni S; Pashov A; Cayla M; Tabarin F; Jablonski M; Hue C; Smith RJ; Noris M; Halbwachs-Mecarelli L; Donadelli R; Fremeaux-Bacchi V; Roumenina LT
J Am Soc Nephrol; 2014 Sep; 25(9):2053-65. PubMed ID: 24652797
[TBL] [Abstract][Full Text] [Related]
20. A structurally dynamic N-terminal helix is a key functional determinant in staphylococcal complement inhibitor (SCIN) proteins.
Garcia BL; Summers BJ; Ramyar KX; Tzekou A; Lin Z; Ricklin D; Lambris JD; Laity JH; Geisbrecht BV
J Biol Chem; 2013 Jan; 288(4):2870-81. PubMed ID: 23233676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
